Polycystic ovary syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), a change that reflects the condition's true nature as a whole-body hormonal and metabolic disorder affecting an estimated one in eight women worldwide. The rename, published in The Lancet in May 2026 after 14 years of global advocacy, aims to improve diagnosis, reduce stigma, and ensure women receive comprehensive care beyond reproductive health alone.

Why Did PCOS Get a New Name?

The old name was misleading in several critical ways. "Polycystic" suggests the presence of ovarian cysts, but many women with the condition do not have cysts at all. The name also over-focused on the ovaries, ignoring the fact that this is a whole-body condition affecting metabolism, weight, mental health, and skin alongside reproductive function. This narrow framing led to misunderstandings, missed diagnoses, and fragmented care with too much focus on fertility and not enough on long-term health risks.

The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), better reflects what the condition actually is: a complex hormonal and metabolic disorder that affects multiple body systems. The change is intended to redirect attention toward how these systems interact to shape a woman's long-term health, rather than framing the condition as a purely ovarian issue.

What Symptoms Should You Watch For?

PMOS is characterized by hormonal fluctuations that can cause a wide range of symptoms across different body systems. If you're experiencing any of the following, speak to your gynecologist for evaluation and testing:

• Menstrual Cycle Changes: Irregular periods, missed periods, or no periods at all due to disrupted ovulation patterns
• Fertility Concerns: Difficulty getting pregnant due to irregular or absent ovulation, which may require specialized reproductive care
• Hormonal Signs: Higher-than-normal levels of male hormones (androgens) causing excess facial or body hair, acne, oily skin, or female-pattern hair loss
• Weight and Metabolism Issues: Weight gain, difficulty losing weight, and insulin resistance that affects how your body processes blood sugar
• Mental Health Changes: Increased risk of anxiety, depression, and low mood, which are now recognized as part of the condition's broader impact

How Does the Rename Change Your Care?

The good news is that your diagnosis and treatment remain valid. The name change does not mean you have a new condition; it means the medical community now has a more accurate name for the condition you already have. However, the rename is designed to improve care in several meaningful ways.

First, the new name should help women get diagnosed sooner. The old name often led to delays in diagnosis because doctors and patients focused too narrowly on the ovaries. The new name highlights the broader health implications, which should prompt faster recognition and evaluation.

Second, PMOS is now recognized as a lifelong health issue, not just a fertility problem. This means your healthcare team should consider all aspects of your health, including metabolic and weight-related factors, mental health, and cardiovascular risks, not just your reproductive health. In practice, this might mean your gynecologist working alongside a dietitian, endocrinologist, or mental health professional, so that your metabolic, cardiovascular, and emotional health are monitored alongside your reproductive care.

Third, the new name is designed to be clearer and less stigmatizing. Many women found the old name confusing or felt it reduced their condition to a single body part.

What Long-Term Health Risks Should You Know About?

Women with PMOS have an increased risk of several other health conditions that require ongoing monitoring and preventive care:

• Type 2 Diabetes: Insulin resistance associated with PMOS significantly increases the risk of developing diabetes later in life
• High Blood Pressure and Heart Disease: Metabolic changes and hormonal imbalances increase cardiovascular risk, requiring regular blood pressure and cholesterol monitoring
• Gestational Diabetes During Pregnancy: Women with PMOS who become pregnant face higher risk of developing diabetes during pregnancy, which requires specialized prenatal care
• Mental Health Conditions: Anxiety and depression occur at higher rates in women with PMOS and should be screened for regularly as part of comprehensive care

What Should You Ask Your Healthcare Provider?

As the medical community transitions to the new name and guidelines, you can take an active role in ensuring you receive comprehensive care. A new international guideline on PMOS is expected to be published in December 2026, with a three-year global transition period for full implementation. In the meantime, ask your clinician about the following:

• Metabolic Checks: Request regular screening for blood sugar levels, cholesterol, and blood pressure to monitor your metabolic health and catch early warning signs of diabetes or heart disease
• Mental Health Screening: Ask about anxiety and depression screening as part of your routine care, since these conditions are now recognized as part of PMOS
• Individualized Reproductive Care: Discuss your fertility goals and any concerns about pregnancy, as treatment options vary based on whether you're planning to conceive

Both the old term "PCOS" and the new term "PMOS" will coexist for a while, and many women will still recognize and use "PCOS." The rename does not erase that history; it simply reflects a more accurate understanding of the condition moving forward. Your current treatments remain valid, and treatment options may include lifestyle changes, hormonal contraception, medications to manage insulin resistance like metformin, and fertility treatments if needed.

" }